The specialist physician's approach to rheumatoid arthritis in South Africa.
- Author:
Frederik C J BESTER
1
;
Fredricka J BOSCH
;
Barend J Jansen VAN RENSBURG
Author Information
- Publication Type:Review
- Keywords: Rheumatoid arthritis management; Biological disease-modifying anti-rheumatic drug; Rheumatoid arthritis criteria; South Africa
- MeSH: Antirheumatic Agents/adverse effects/*therapeutic use; Arthritis, Rheumatoid/diagnosis/*drug therapy/epidemiology; Diffusion of Innovation; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prevalence; *Rheumatologists/standards; Risk Factors; Severity of Illness Index; South Africa/epidemiology; *Specialization; Treatment Outcome
- From:The Korean Journal of Internal Medicine 2016;31(2):219-236
- CountryRepublic of Korea
- Language:English
- Abstract: Rheumatoid arthritis (RA) is expected to increase in Africa and South Africa. Due to the low numbers of rheumatologists in South Africa, specialist physicians also have to care for patients with RA. Furthermore several new developments have taken place in recent years which improved the management and outcome of RA. Classification criteria were updated, assessment follow-up tools were refined and above all, several new biological disease-modifying anti-rheumatic drugs were developed. Therefore it is imperative for specialist physicians to update themselves with the newest developments in the management of RA. This article provides an overview of the newest developments in the management of RA in the South African context. This approach may well apply to countries with similar specialist to patient ratios and disease profiles.
